Compumedics ranked #22 Holder of Pervasive Neurotech Intellectual Property*

Com­pumedics devel­ops diag­nos­tic devices for sleep (polysomnog­ra­phy) and oth­er neu­ro­log­i­cal con­di­tions (EEG, EMG, epilep­sy, TCD). Their prod­ucts fall under the brands Grael, E‑series, Somte, Sies­ta, and Safiro and are aimed at hos­pi­tals, clin­ics, and home ser­vice providers. Found­ed in 1987, Com­pumedics remains a pri­vate company.

• Loca­tion: Abbots­ford, Australia
• Stock Tick­er: ASX:CMP
• Num­ber of employ­ees: 100–999
• Per­va­sive neu­rotech US patent grants: 13
• Per­va­sive neu­rotech US pend­ing appli­ca­tions: 6

*Com­pumedics ranked #22 in Sharp­Brains’ Per­va­sive Neu­rotech IP Strength Index, thanks to patents such as:

• US7840248: Online source recon­struc­tion for eeg/meg and ecg/mcg
• US6575902: Vig­i­lance mon­i­tor­ing system
• US8069852: Method and appa­ra­tus for main­tain­ing and mon­i­tor­ing sleep qual­i­ty dur­ing ther­a­peu­tic treatments

To learn more about Sharp­Brains’ take on the orga­ni­za­tion’s #Per­va­siveNeu­rotech IP port­fo­lio, and over­all data and trends, click on Per­va­sive Neu­rotech­nol­o­gy: A Ground­break­ing Analy­sis of 10,000+ Patent Fil­ings Trans­form­ing Med­i­cine, Health, Enter­tain­ment, and Busi­ness.